ICyte Platform

ICyte is the first data, analytics, and business process platform built specifically for pharmaceutical market access.

Pharmaceutical organizations of all sizes and complexity rely on the ICyte platform to streamline market access and therapy commercialization. ICyte provides biotech and pharma manufacturers with world-class channel and patient data aggregation, contracts and pricing managed services, gross-to-net forecasting and accrual systems and expert launch and pricing transparency solutions.

With ICyte, pharmaceutical and biotech companies improve market access by quickly transforming patient, payer, complex transaction, and channel data into actionable insight.

There are three main components of the ICyte Platform: ICyte Applications, ICyte Analytics, and ICyte Data Refinery, which are supported by Governance and Cloud Infrastructure capabilities.


 The ICyte platform offers numerous tools that improve market access for pharma and biotech companies, including Applications, Analytics, Data Refinery, Governance, and Infrastructure.

Market Access Platform Capabilities

ICyte Analytics Portal

Unlike most enterprise systems, ICyte Analytics makes it easy to access data and insights. The unified portal interface provides pharmaceutical manufacturers with single sign-on access across all ICyte channel, patient, contracts, pricing, and gross-to-net data and applications to easily create custom data-on-demand reporting and visualizations in one consolidated, easy-to-navigate website. Market Access teams will find it easy to visualize, extract, and integrate data into existing workflows and get the data they need when they need it. The platform also has a robust API that enables the use of existing business intelligence (BI) tools, if desired.

ICyte also supports analytics-as-a-service, which allows common models and metrics to be deployed as a centralized service across applications, data, and analytics uses. Key performance indicators (KPIs) specific to pharmaceutical companies are built into the platform. Also included are advanced analytics such as forecasting, scenario modeling, and a machine-learning-powered recommendation engine.


icyte analytics

ICyte Data Refinery

Data Acquisition

The ICyte Platform supports multiple data acquisition technologies to onboard data securely. In addition to supporting all IntegriChain applications, ICyte’s data acquisition technologies make raw data actionable via direct, electronic data interchange (EDI), remote process automation (RPA), optical character recognition (OCR), and other data acquisition techniques. Our pre-built connectors and application programming interfaces (APIs) enable automation and reliable integration of data from third-party systems.

Comprehensive Data Sets

ICyte utilizes a wide array of data sets to support market access including:

Direct Sales & Channel Data

  • Chargebacks
  • Rebates
  • EDI 867, 852, 844, and 849 transaction data

Payer Data

  • Invoices
  • Contracts Rebates
  • Discounts Fees

Patient Data

  • Rx claims
  • Dispense data
  • Patient status data
  • Reimbursements
  • Patient assistance data

Data Integrity

The ICyte Platform uses data standardization and master data practices that ensure data quality across all IntegriChain products. The common repository supports a unified Market Access data model—an enterprise-class master data management (MDM) framework for products, customers, pricing, and more—and powers all IntegriChain applications, data, and analytics offerings. The repository supports data audit and lineage as well as a robust data lifecycle management process.


The ICyte Platform features an orchestration layer that defines and automates processes with sufficient provisions for process governance and benchmarking by leveraging services for job management, business rules management, workflow automation, and workload management.

Operational Benefits

Pharmaceutical companies that use ICyte for their market access needs see a wealth of operational benefits including:

Hassle-free Integration

The ICyte Platform easily integrates with leading revenue management applications, CRMs, ERPs, third-party sources, and datasets.

Seamless Interoperability with IntegriChain Products

The common architecture also means IntegriChain applications will integrate seamlessly with each other, regardless of when they’re purchased, and provide a standard way to publish data to enterprise/commercial data warehouses.

Investment Protection

The ICyte Platform is specifically designed to service market access functions. It co-exists with existing IT investments and infrastructure across CRM, ERP, data warehouse, and analytics systems.

Reduced Risk

The ICyte Platform is built with inherent security and scalability considerations. It is SOC 2 compliant and is hosted on AWS, leveraging proven and modern technology foundations to serve customers. All access to data is through secure protocols and encrypted in our services with the latest standards.

Maximize Value

Pharma manufacturers realize lower costs due to reduced vendor mix, less contracting complexity, and elimination of duplicate services.



All of IntegriChain’s products and services built on the ICyte Platform have a common configuration backbone. This not only accelerates time-to-value for pharmaceutical companies but also enables application interaction through shared metadata.

cloud infrastructure

Enterprise-Grade Cloud Infrastructure

The ICyte Platform was developed with the largest and most dynamic pharmaceutical manufacturers in mind. Underneath, it is a fully-hosted SOC 2 certified cloud platform designed on a scalable, high-availability architecture and market-proven open source technologies.

Interested in learning more?

Request ICyte Platform information

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper